These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

622 related items for PubMed ID: 19427836

  • 1. c-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells.
    Kim MS, Kim SY, Arunachalam S, Hwang PH, Yi HK, Nam SY, Lee DY.
    Biochem Biophys Res Commun; 2009 Jul 17; 385(1):38-43. PubMed ID: 19427836
    [Abstract] [Full Text] [Related]

  • 2. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
    Wang Z, Chakravarty G, Kim S, Yazici YD, Younes MN, Jasser SA, Santillan AA, Bucana CD, El-Naggar AK, Myers JN.
    Clin Cancer Res; 2006 Aug 01; 12(15):4755-65. PubMed ID: 16899627
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) on endometrial cancer (HHUA) cell apoptosis and EGF stimulated cell proliferation in vitro.
    Mochizuki T, Sakai K, Iwashita M.
    Growth Horm IGF Res; 2006 Jun 01; 16(3):202-10. PubMed ID: 16844395
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adenovirus-mediated expression of dominant negative c-myb induces apoptosis in head and neck cancer cells and inhibits tumor growth in animal model.
    Kim SY, Yang YS, Hong KH, Jang KY, Chung MJ, Lee DY, Lee JC, Yi HK, Nam SY, Hwang PH.
    Oral Oncol; 2008 Apr 01; 44(4):383-92. PubMed ID: 17690006
    [Abstract] [Full Text] [Related]

  • 8. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
    Burtrum D, Zhu Z, Lu D, Anderson DM, Prewett M, Pereira DS, Bassi R, Abdullah R, Hooper AT, Koo H, Jimenez X, Johnson D, Apblett R, Kussie P, Bohlen P, Witte L, Hicklin DJ, Ludwig DL.
    Cancer Res; 2003 Dec 15; 63(24):8912-21. PubMed ID: 14695208
    [Abstract] [Full Text] [Related]

  • 9. Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation.
    Bermont L, Fauconnet S, Lamielle F, Adessi GL.
    Cell Mol Biol (Noisy-le-grand); 2000 Nov 15; 46(7):1173-82. PubMed ID: 11075947
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
    Yi HK, Kim SY, Hwang PH, Kim CY, Yang DH, Oh Y, Lee DY.
    Biochem Biophys Res Commun; 2005 May 13; 330(3):760-7. PubMed ID: 15809062
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
    Hermani A, Shukla A, Medunjanin S, Werner H, Mayer D.
    Cell Signal; 2013 Jun 13; 25(6):1395-402. PubMed ID: 23499909
    [Abstract] [Full Text] [Related]

  • 15. Epidermal growth factor-induced activation of the insulin-like growth factor I receptor in rat hepatocytes.
    Hallak H, Moehren G, Tang J, Kaou M, Addas M, Hoek JB, Rubin R.
    Hepatology; 2002 Dec 13; 36(6):1509-18. PubMed ID: 12447877
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone suppresses the expression of IGFBP-5, and promotes the IGF-I-induced phosphorylation of Akt in bovine mammary epithelial cells.
    Sakamoto K, Yano T, Kobayashi T, Hagino A, Aso H, Obara Y.
    Domest Anim Endocrinol; 2007 May 13; 32(4):260-72. PubMed ID: 16698222
    [Abstract] [Full Text] [Related]

  • 17. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
    Schlenska-Lange A, Knüpfer H, Lange TJ, Kiess W, Knüpfer M.
    Anticancer Res; 2008 May 13; 28(2A):1055-60. PubMed ID: 18507054
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions.
    Moralez AM, Maile LA, Clarke J, Busby WH, Clemmons DR.
    J Cell Physiol; 2005 May 13; 203(2):328-34. PubMed ID: 15700281
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor-1 provides protection against psychosine-induced apoptosis in cultured mouse oligodendrocyte progenitor cells using primarily the PI3K/Akt pathway.
    Zaka M, Rafi MA, Rao HZ, Luzi P, Wenger DA.
    Mol Cell Neurosci; 2005 Nov 13; 30(3):398-407. PubMed ID: 16169744
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.
    Haluska P, Carboni JM, Loegering DA, Lee FY, Wittman M, Saulnier MG, Frennesson DB, Kalli KR, Conover CA, Attar RM, Kaufmann SH, Gottardis M, Erlichman C.
    Cancer Res; 2006 Jan 01; 66(1):362-71. PubMed ID: 16397250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.